November 11, 2021
- The Technion
- November 11, 2021
- No comments
Researchers at the Faculty of Materials Science and Engineering at the Technion succeeded in changing the electrical properties of a material by removing an oxygen atom from the original structure. Possible applications: electronic miniaturization and detection of radiation emissions
- The Hebrew University
- November 11, 2021
A new study conducted in collaboration between the Institute of Chemistry at the Hebrew University and the University of Lausanne in Switzerland tries to disrupt the future activities of criminals who specialize in forging fingerprints and thus prevent information security breaches. "If we know what the next generation of fingerprint forgeries will look like, we can prepare a countermeasure ahead of time"
- The Hebrew University
- November 11, 2021
A new study reveals that the increase in the concentration of greenhouse gases will lead to the intensification of extreme storms, along with a decrease of about 25 percent in the amount of rainfall. The gloomy forecast, but the researchers believe: "The control is still in our hands"
- Avi Blizovsky
- November 11, 2021
- No comments
"Researchers can accelerate their quantum computing work using our cuQuantum SDK on popular services or a new device based on the NVIDIA DGX system." says Hansen Huang, CEO of Nvidia"
- Avi Blizovsky
- November 11, 2021
- No comments
The Israeli Newreality is the first chip start-up company in the world to be chosen to join IBM's AI Hardware Center * Dr. Mukesh Kahara, IBM: "The association with Newreality, which developed the unique AI-centric approach, is the type of collaboration we are looking for"
- The science service
- November 11, 2021
- No comments
The company, which also operates a development center in Haifa, develops artificial intelligence for the eye scanning market
- Avi Blizovsky
- November 11, 2021
- No comments
Following the achievements of the project, the Innovation Authority will grant an additional budget to promote the activities of the national association CRISPR-IL, in which Pluristem leads the pharmaceutical group and within which it works in collaboration with other leading parties in the field of genome editing in industry and academia